The role of laminin-integrin signaling in triggering MB formation. An in vivo and in vitro study (Q46493011)

22 December 2017

title

The role of laminin-integrin signaling in triggering MB formation. An in vivo and in vitro study (English)

1 reference

22 December 2017

author name string

Yong Wu

1

1 reference

22 December 2017

Li Nan

2

1 reference

22 December 2017

Fawzia Bardag-Gorce

3

1 reference

22 December 2017

Jun Li

4

1 reference

22 December 2017

Barbaba A French

5

1 reference

22 December 2017

La Toyia Wilson

6

1 reference

22 December 2017

Jennifer Dedes

7

1 reference

22 December 2017

Samuel W French

8

1 reference

22 December 2017

publication date

1 August 2005

1 reference

22 December 2017

Experimental and Molecular Pathology

published in

1 reference

22 December 2017

volume

79

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

page(s)

1-8

1 reference

22 December 2017

The role of the ubiquitin-proteasome pathway in the formation of mallory bodies

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.03.005

The mechanism of cytokeratin aggresome formation: the role of mutant ubiquitin (UBB+1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.03.005

Proteasome inhibition induces cytokeratin accumulation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.03.005

Nonalcoholic steatohepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.03.005

7 January 2021

Conformational disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.03.005

Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.03.005

Aggresome formation in liver cells in response to different toxic mechanisms: role of the ubiquitin-proteasome pathway and the frameshift mutant of ubiquitin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.03.005

The mallory body: Morphological, clinical and experimental studies (part 1 of a literature survey)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.03.005

Molecular structural changes in Mallory body proteins in human and mouse livers: an infrared spectroscopy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.03.005

Ethanol-induced phosphorylation of cytokeratin in cultured hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.03.005

Molecular misreading of the ubiquitin B gene and hepatic mallory body formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.03.005

Integrin function: molecular hierarchies of cytoskeletal and signaling molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.03.005

Matrix/integrin interaction activates the mitogen-activated protein kinase, p44erk-1 and p42erk-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.03.005

p62 is involved in the mechanism of Mallory body formation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.03.005

RNA interference of VCP/p97 increases Mallory body formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.03.005

The p105/50 NF-kappaB pathway is essential for Mallory body formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.03.005

Microtubules are required for cytokeratin aggresome (Mallory body) formation in hepatocytes: an in vitro study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.03.005

Focal adhesion kinase overexpression enhances ras-dependent integrin signaling to ERK2/mitogen-activated protein kinase through interactions with and activation of c-Src

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.03.005

Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: summation of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.03.005

Integrins: emerging paradigms of signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.03.005

Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.03.005

Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.03.005

The essentiality of Bcl-2, PKC and proteasome–ubiquitin complex activations in the neuroprotective-antiapoptotic action of the anti-Parkinson drug, rasagiline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.03.005

Mallory body induction in drug-primed mouse liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.03.005

Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.03.005

p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2005.03.005

10.1016/J.YEXMP.2005.03.005

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017